You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Related products

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

Anti-Cytokeratin 5 antibody (ab53121)

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-Cytokeratin 5 antibody
See all Cytokeratin 5 products (13) ...

Description

Rabbit polyclonal to Cytokeratin 5

Specificity

ab53121 detects endogenous levels of total Cytokeratin 5 protein.

Tested applications

ELISA, IHC-P, ICC/IF, IHC-FoFr, WBmore details

Cross reactivity

Reacts with

Mouse, Human, Pig

Immunogen

A synthetic peptide derived from human Cytokeratin 5.

Positive control

HepG2 cell extracts and human breast carcinoma tissue.

Properties

Form

Liquid

Storage instructions

Store at -20°C. Stable for 12 months at -20°C

Storage buffer

Preservative: 0.02% Sodium Azide
Constituents: 50% Glycerol, PBS (without Mg2+ and Ca2+), 150mM Sodium chloride, pH 7.4

Concentration

Concentration information loading...

Purity

Immunogen affinity purified

Purification notes

ab53121 was affinity purified from rabbit antiserum by affinity chromatography using epitope specific immunogen.

Clonality

Polyclonal

Isotype

IgG

  • Western blot - Cytokeratin 5 antibody (ab53121)Western blot - Cytokeratin 5 antibody (ab53121) image (enlarge)

  • Immunohistochemistry (Paraffin-embedded sections) - Cytokeratin 5 antibody (ab53121)Immunohistochemistry (Paraffin-embedded sections) - Cytokeratin 5 antibody (ab53121) image (enlarge)

  • Immunocytochemistry/ Immunofluorescence-Cytokeratin 5 antibody(ab53121)Immunocytochemistry/ Immunofluorescence-Cytokeratin 5 antibody(ab53121) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab53121 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • ELISA

     ELISA: 1/10000

    ELISA: 1/10000

  • 1 Image

    IHC-P

     IHC-P: 1/50 - 1/100.

    IHC-P: 1/50 - 1/100.

  • ShowHide1 Image

    ICC/IF

     ICC/IF: Use a concentrat...Read more →

    ICC/IF: Use a concentration of 1 µg/ml

  • ShowHide

    IHC-FoFr

     IHC-FoFr: Use at an assa...Read more →

    IHC-FoFr: Use at an assay dependent dilution. (PubMed: 21278345)

  • ShowHide1 Image

    WB

     WB: 1/300 - 1/1000.Detec...Read more →

    WB: 1/300 - 1/1000.Detects a band of approximately 62 kDa (predicted molecular weight: 62 kDa).

Target

Involvement in disease

Defects in KRT5 are a cause of epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760]. DM-EBS is a severe form of intraepidermal epidermolysis bullosa characterized by generalized herpetiform blistering, milia formation, dystrophic nails, and mucous membrane involvement.
Defects in KRT5 are the cause of epidermolysis bullosa simplex with migratory circinate erythema (EBSMCE) [MIM:609352]. EBSMCE is a form of intraepidermal epidermolysis bullosa characterized by unusual migratory circinate erythema. Skin lesions appear from birth primarily on the hands, feet, and legs but spare nails, ocular epithelia and mucosae. Lesions heal with brown pigmentation but no scarring. Electron microscopy findings are distinct from those seen in the DM-EBS, with no evidence of tonofilament clumping.
Defects in KRT5 are a cause of epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800]. WC-EBS is a form of intraepidermal epidermolysis bullosa characterized by blistering limited to palmar and plantar areas of the skin.
Defects in KRT5 are a cause of epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900]. K-EBS is a form of intraepidermal epidermolysis bullosa characterized by generalized skin blistering. The phenotype is not fundamentally distinct from the Dowling-Meara type, althought it is less severe.
Defects in KRT5 are the cause of epidermolysis bullosa simplex with mottled pigmentation (MP-EBS) [MIM:131960]. MP-EBS is a form of intraepidermal epidermolysis bullosa characterized by blistering at acral sites and 'mottled' pigmentation of the trunk and proximal extremities with hyper- and hypopigmentation macules.
Defects in KRT5 are the cause of Dowling-Degos disease (DDD) [MIM:179850]; also known as Dowling-Degos-Kitamura disease or reticulate acropigmentation of Kitamura. DDD is an autosomal dominant genodermatosis. Affected individuals develop a postpubertal reticulate hyperpigmentation that is progressive and disfiguring, and small hyperkeratotic dark brown papules that affect mainly the flexures and great skin folds. Patients usually show no abnormalities of the hair or nails.

Sequence similarities

Belongs to the intermediate filament family.

Target information above from: UniProt accessionP13647 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • type II cytoskeletal 5 antibody
  • 58 kDa cytokeratin antibody
  • CK 5 antibody
  • CK-5 antibody
  • CK5 antibody
  • Cytokeratin-5 antibody
  • Cytokeratin5 antibody
  • DDD antibody
  • EBS 2 antibody
  • EBS2 antibody
  • K2C5_HUMAN antibody
  • K5 antibody
  • Keratin 5 (epidermolysis bullosa simplex Dowling-Meara/Kobner/Weber-Cockayne types) antibody
  • Keratin 5 antibody
  • Keratin antibody
  • Keratin Type II Cytoskeletal 5 antibody
  • Keratin-5 antibody
  • Keratin5 antibody
  • KRT 5 antibody
  • KRT 5A antibody
  • KRT5 antibody
  • KRT5A antibody
  • Type-II keratin Kb5 antibody
see all

Anti-Cytokeratin 5 antibody images:

  Western blot - Cytokeratin 5 antibody (ab53121)

Western blot - Cytokeratin 5 antibody (ab53121)

All lanes : Anti-Cytokeratin 5 antibody (ab53121) at 1/300 dilution

Lane 1 : HepG2 cell extract
Lane 2 : HepG2 cell extract with immunising peptide


Predicted band size : 62 kDa
Observed band size : 62 kDa

  Immunohistochemistry (Paraffin-embedded sections) - Cytokeratin 5 antibody (ab53121)

Immunohistochemistry (Paraffin-embedded sections) - Cytokeratin 5 antibody (ab53121)

ab53121 at 1/50 dilution staining Cytokeratin 5 in human breast carcinoma by Immunohistochemistry, Paraffin embedded tissue, in the absence and presence of the immunising peptide.

  Immunocytochemistry/ Immunofluorescence-Cytokeratin 5 antibody(ab53121)

Immunocytochemistry/ Immunofluorescence-Cytokeratin 5 antibody(ab53121)

ICC/IF image of ab53121 stained MCF7 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab53121, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-Cytokeratin 5 antibody (ab53121)

This product has been referenced in:

  • Sanos SLet al. Stromal cell networks regulate thymocyte migration and dendritic cell behavior in the thymus. J Immunol 186:2835-41 (2011). IHC-FoFr; Mouse.Read more (PubMed: 21278345) »

See 1 publication for this product

Publishing research using ab53121? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"